Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Xihuang Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Dalian Medical University, Dalian, 116027, China. Hauptthemen laut MEDLINE: Berberine, Pancreatic Neoplasms, Neoplastic Stem Cells, Silicon Dioxide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Foundation of Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province.
Abstract (Originalsprache)
Objectives
To investigate the anti-pancreatic ductal adenocarcinoma (PDAC) effect of mesoporous silica nanoparticles loaded with berberine (MSN-BBR) both in vitro and in vivo.
Methods
Disulfide-bridged MSN loaded with berberine (BBR) was synthesized and characterized. The study assessed the anti-PDAC effect and the impact on the stemness of pancreatic cancer stem cells (PCSCs) in Panc1 cells and mice. Pathological morphology in the pancreas of mice was evaluated through immunohistochemical and immunofluorescence staining, while protein expressions were analyzed via western blot. Key findings MSN-BBR glutathione-degraded and released BBR. Moreover, MSN-BBR demonstrated the inhibition of Panc1 cell viability and the stemness ability of PCSC by suppressing the epithelial-mesenchymal transition (EMT) pathway. Consistent with these cellular outcomes, MSN-BBR also impeded the growth of pancreatic tumors by specifically targeting PCSC.
Conclusions
MSN-BBR exhibited degradation and BBR release ability. Notably, MSN-BBR exhibited enhanced efficacy in combating PDAC by selectively focusing on PCSC compared to BBR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital of Dalian Medical University, Dalian, 116027, China.
- Central Hospital of Dalian University of Technology, Dalian, 116033, China.
- Department of Medicine, Dalian University of Technology, Dalian, 116023, China.
- Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
ORCID-Profile: Yanping Li
Förderung
- Fundamental Research Funds for the Central Universities
- Foundation of Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province
Zitieren
APA
Cao, X., Pang, S., Li, Y., Song, X., Tang, H., Lv, H., Luo, F., & Pan, Y. (2025). Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf058
Vancouver
Cao X, Pang S, Li Y, Song X, Tang H, Lv H, et al. Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf058
BibTeX
@article{Cao2025,
author = {Cao, Xihuang and Pang, Songyuan and Li, Yanping and Song, Xue and Tang, Huan and Lv, Hong and Luo, Fuwen and Pan, Yue},
title = {Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf058}
}
EUVIMED